Back to Search

QoL Study for Choroidal Melanoma Patients

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

Recruiting Observational Study
Choroidal Melanoma Indeterminate Lesions Uveal Melanoma Ocular Melanoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
15 (estimated)
Sponsor
Aura Biosciences · Industry
Who this trial is looking for

This trial is looking for people who have already joined another study about a treatment for choroidal melanoma. If you take part, you'll share your experiences and quality of life while using a connected device like a smartphone or tablet.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have enrolled in the clinical trial AU-011-301.
  • I have access to a connected device like a smartphone or tablet.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.

Trial Locations

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Have enrolled in the Aura-sponsored clinical trial AU-011-301. * Access to a connected device (i.e., smartphone, laptop, or tablet) Exclusion Criteria: * None
Contacts

Medical Monitor

617-500-8864

clinical@aurabiosciences.com

CONTACT

NCT ID: NCT07421739 Source: ClinicalTrials.gov